Search Results - Da-Lin HE
- Showing 1 - 12 results of 12
-
1
-
2
-
3
PSA time to nadir as a prognostic factor of first-line docetaxel treatment in castration-resistant prostate cancer: evidence from patients in Northwestern China by Kai-Jie Wu, Xin-Qi Pei, Ge Tian, Da-Peng Wu, Jin-Hai Fan, Yu-Mei Jiang, Da-Lin He
Published in Asian Journal of Andrology (2018-01-01)Get full text
Article -
4
-
5
-
6
Relationships among androgen receptor CAG repeat polymorphism, sex hormones and penile length in Han adult men from China: a cross-sectional study by Yan-Min Ma, Kai-Jie Wu, Liang Ning, Jin Zeng, Bo Kou, Hong-Jun Xie, Zhen-Kun Ma, Xin-Yang Wang, Yong-Guang Gong, Da-Lin He
Published in Asian Journal of Andrology (2014-06-01)Get full text
Article -
7
Effects of 450nm semiconductor blue laser on the vaporization and incision of endometrial tissue ex vivo by Guo-Xiong LIU, Li-Hong CHEN, Fen Li3, Yan XUE, Da-Li JIANG, Xiao-Feng XU, Rui-Fang AN, Xin-Yang WANG, Xi-Min QIAO, Da-Lin HE, Kai-Jie WU
Published in Yixue xinzhi zazhi (2023-02-01)Get full text
Article -
8
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019 by Hao Zi, Shao-Hua He, Xie-Yuan Leng, Xiao-Feng Xu, Qiao Huang, Hong Weng, Cong Zhu, Lu-Yao Li, Jia-Min Gu, Xu-Hui Li, Dao-Jing Ming, Xiao-Dong Li, Shuai Yuan, Xing-Huan Wang, Da-Lin He, Xian-Tao Zeng
Published in Military Medical Research (2021-11-01)Get full text
Article -
9
Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial by Byung Ha Chung, Jian Huang, Hiroji Uemura, Young Deuk Choi, Zhang-Qun Ye, Hiroyoshi Suzuki, Taek Won Kang, Da-Lin He, Jae Young Joung, Sabine D Brookman-May, Sharon McCarthy, Amitabha Bhaumik, Anildeep Singh, Suneel Mundle, Simon Chowdhury, Neeraj Agarwal, Ding-Wei Ye, Kim N Chi, Hirotsugu Uemura
Published in Asian Journal of Andrology (2023-01-01)Get full text
Article -
10
Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml−1 by Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, Li-Ping Xie, Yi-Ran Huang, Da-Lin He, Xu Gao, Chuan-Liang Xu, Qiang Ding, Qiang Wei, Chang-Jun Yin, Shan-Cheng Ren, Fu-Bo Wang, Ye Tian, Zhong-Quan Sun, Qiang Fu, Lu-Lin Ma, Jun-Hua Zheng, Zhang-Qun Ye, Ding-Wei Ye, Dan-Feng Xu, Jian-Quan Hou, Ke-Xin Xu, Jian-Lin Yuan, Xin Gao, Chun-Xiao Liu, Tie-Jun Pan, Ying-Hao Sun, on behalf of Chinese Prostate Cancer Consortium
Published in Asian Journal of Andrology (2015-01-01)Get full text
Article -
11
Interpretation of the clinical pathway for transurethral plasmakinetic resection of bladder tumor by Si-Yu YAN, Xing HUANG, Zheng CHEN, Lu YANG, Zhao-Hui JIA, Mou PENG, Xuan-Yi REN, Jing XIONG, Xiao-Dong LI, Xiao-Feng XU, Yong-Bo WANG, Xu-Hui LI, Hang ZHENG, Ting WANG, Ying-Hui JIN, Hao ZI, Tong-Zu LIU, Xian-Tao ZENG, Da-Lin HE, Xing-Huan WANG, Urology Professional Committee of Chinese Research Hospital Associa-tion, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care, Project Group for Minimally Invasive Plasmakinetic Surgery System Development and Industrial-ization of the National Key Research and Development Program
Published in Yixue xinzhi zazhi (2022-04-01)Get full text
Article -
12
Clinical pathway interpretation of transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia by Si-Yu YAN, Xing HUANG, Zheng CHEN, Lu YANG, Zhao-Hui JIA, Mou PENG, Xuan-Yi REN, Jing XIONG, Xiao-Dong LI, Xiao-Feng XU, Zhong-Yi SUN, Yong-Bo WANG, Xu-Hui LI, Wan-Li HU, Ting WANG, Ying-Hui JIN, Hao ZI, Tong-Zu LIU, Xian-Tao ZENG, Da-Lin HE, Xing-Huan WANG, Urological Association of Chinese Research Hospital Association, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care, Project Group for Minimally Invasive Plasmakinetic Surgery System Development and Industrialization of the National Key Research and De-velopment Program
Published in Yixue xinzhi zazhi (2022-06-01)Get full text
Article
